Cramer's Top Homebu...
Health Care: Drugs
BioDelivery Sciences International Inc. (BDSI: NASDAQ)
$4.51 0.01 | 0.22%
05/24/13 - 09:31 AM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 1.65M | -23.33M | -13.03M | 33.05M |
| Operating Gains/Losses | 0.00 | -3.46M | -3.13M | 2.40K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -419.68K | 530.54K | 635.53K | -809.72K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 5.57M | 407.44K | 809.52K | 216.16K |
| (Decrease) Increase In Other Current Liabilities | 129.12K | 0.00 | -312.13K | -24.02M |
| (Increase) Decrease In Other Working Capital | -3.45M | 7.13K | 788.98K | 0.00 |
| Other Non-Cash Items | 7.21M | 1.23M | 1.24M | 8.85M |
| Net Cash From Continuing Operations | 12.19M | -23.27M | -11.68M | 18.19M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 12.19M | -23.27M | -11.68M | 18.19M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.09M | -286.97K | -1.10M | -2.75M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -1.09M | -286.97K | -1.10M | -2.75M |
| Issuance of Debt | 0.00 | 7.80K | 0.00 | 1.83M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 41.35M | 2.10M | 97.88K | 5.77M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | -2.72M | -76.66K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -7.80K | 14.00M | 9.75M | 0.00 |
| Net Cash From Financing Activities | 41.34M | 16.10M | 7.12M | 7.53M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 52.44M | -7.46M | -5.66M | 22.97M |
Portfolios with BDSI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- UserWhole Portfolio
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks Under $5 Outperfo...
- Contributor10 Pharma Stocks With 100% ...
Latest BDSI Headlines from TheStreet
- BDSI Makes Notable Cross Below Critical Moving Average 05.17.13 | 11:05 am
- 2 Biotech Stocks Under $10 to Watch 04.11.13 | 02:04 pm
- 5 Stocks Under $10 Set to Explode 02.14.13 | 01:02 pm
- 3 Highly Shorted Stocks Under $5 Being Bought By Hedge Funds 02.01.13 | 01:02 pm
- BioDelivery Sciences International Inc. Stock Downgraded (BDSI) 11.28.12 | 04:11 am
- 10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook 11.27.12 | 06:11 am
- 5 Stocks Under $10 Soaring Higher 09.13.12 | 02:09 pm
- BioDelivery Sciences International Inc. Stock Upgraded (BDSI) 06.06.12 | 05:06 am
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- The Next Big Thing in Biotech: BIO CEO Conference
02.10.12 | 05:02 am
Press Releases for BDSI
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of First Quarter 2013 Financials - PR Newswire 05.09.13 | 04:05 pm
- BioDelivery Sciences To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference - PR Newswire 05.07.13 | 07:05 am
- BioDelivery Sciences Appoints Thomas W. D'Alonzo To Board Of Directors - PR Newswire 04.29.13 | 07:04 am
- BioDelivery Sciences Expands Product Pipeline With Acquisition Of Patented Topical Clonidine Gel For The Treatment Of Painful Diabetic Neuropathy - PR Newswire 03.26.13 | 08:03 am
- BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its 2012 Annual Report - PR Newswire 03.18.13 | 04:03 pm
- BioDelivery Sciences To Present At The 25th Annual ROTH Conference - PR Newswire 03.13.13 | 07:03 am
- BioDelivery Sciences To Present At The Cowen And Company 33rd Annual Health Care Conference - PR Newswire 03.01.13 | 08:03 am
- INVESTOR ALERT: Former Attorney General Of Louisiana And Kahn Swick & Foti, LLC Investigate BioDelivery Sciences International, Inc., Following Notice Of Non-Reliance Of Financial Statements And Restatement - Business Wire 02.28.13 | 11:02 pm
- BioDelivery Sciences To Host Buprenorphine Investor And Analyst Event - PR Newswire 02.27.13 | 07:02 am
- BioDelivery Sciences To Present At The 15th Annual BIO CEO And Investor Conference - PR Newswire 02.05.13 | 07:02 am
Partner Headlines for BDSI
- 5 Medical Stock Losers From Last Week With High Short Ratios - Seeking Alpha 12.22.12 | 06:12 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.13.12 | 09:11 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 10.22.12 | 09:10 am
- Pipeline Progress at BioDelivery - Analyst Blog - NASDAQ 08.24.12 | 09:08 pm
- Pipeline Progress at BioDelivery - Analyst Blog - Zacks 08.24.12 | 05:08 pm
- Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX - GuruFocus 07.17.12 | 01:07 pm
- A Closer Look at Shares Getting New Coverage Today - Wall St. Cheat Sheet 07.03.12 | 02:07 am
- Best Performing Stocks At 2012's Midpoint - Seeking Alpha 06.29.12 | 07:06 pm
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Stocks To Watch: Week Of March 19-23 - Seeking Alpha 03.21.12 | 08:03 am
